BSEInsider Trading / SAST29 Sept 2026 · 29 Sept 2026, 10:04 am

Closure of trading window

Parmax Pharma Ltd · 540359

✦ AI Summary

Parmax Pharma Ltd has announced the closure of the trading window for its designated persons from October 1, 2026, until 48 hours after the declaration of the financial results for the quarter and half year ending September 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Parmax Pharma Ltd - 540359 - Closure of Trading Window

Attachments (1)

📄

347a80a7-2af9-4b23-ae6c-7bed673598db.pdf

pdf

Download →
View document text
Date: September 29, 2026 The Department of Corporate Services, BSE Limited, Mumbai BSE Script Code: 540359 Dear Sir/ Madam, SUB: INTIMATION OF CLOSURE OF TRADING WINDOW AS PER THE SEBI (PROHIBITION OF INSIDER TRADING) REGULATIONS, 2015 FOR QUARTER AND HALF YEAR ENDING ON SEPTEMBER 30, 2026 In terms of provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and Company’s Code of Conduct to regulate, monitor and report trading by Designated Persons, the Trading Window for dealing in securities of the Company by Designated Persons shall remain closed from October 01, 2026 till 48 hours after the declaration of the financial results for the quarter and half year ending on September 30, 2026 for all designated persons of the Company. The date of the Board Meeting at which the said results will be considered shall be intimated in due course of time. Thanking you. Yours faithfully, For, Parmax Pharma Limited Umang Alkesh Gosalia Managing Director DIN: 05153830